Selection of lower cutoff point of [13C]urea breath test is helpful to monitor H. pylori eradication after proton pump inhibitor-based triple therapy.
about
Antibiotic treatment for Helicobacter pylori: Is the end coming?Consensus on the clinical management, screening-to-treat, and surveillance of Helicobacter pylori infection to improve gastric cancer control on a nationwide scale.An optimized 13C-urea breath test for the diagnosis of H pylori infection.Posttreatment 13C-urea breath test is predictive of antimicrobial resistance to H. pylori after failed therapyEffective regimens for the treatment of Helicobacter pylori infection.Prevalence of Helicobacter pylori infection in duodenal ulcer and gastro-duodenal ulcer diseases in Taiwan.Impact of intravenous omeprazole on Helicobacter pylori eradication by triple therapy in patients with peptic ulcer bleeding.Impact of supplement with Lactobacillus- and Bifidobacterium-containing yogurt on triple therapy for Helicobacter pylori eradication.Vitamin C and E supplements to lansoprazole-amoxicillin-metronidazole triple therapy may reduce the eradication rate of metronidazole-susceptible Helicobacter pylori infection.Quadruple therapy containing amoxicillin and tetracycline is an effective regimen to rescue failed triple therapy by overcoming the antimicrobial resistance of Helicobacter pylori.Stool antigen assay to screen H. pylori infection and to assess the success of 3-Day and 7-Day eradication therapy in the patients with partial gastrectomy.Esomeprazole 40 mg twice daily in triple therapy and the efficacy of Helicobacter pylori eradication related to CYP2C19 metabolism.Long-term follow-up of 13C-urea breath test results after Helicobacter pylori eradication: frequency and significance of borderline delta13CO2 values.Erythrocyte Lewis (A+B-) host phenotype is a factor with familial clustering for increased risk of Helicobacter pylori-related non-cardiac gastric cancer.
P2860
Q26777623-FCD0071F-B3B3-4850-9799-B980B3ADC52DQ33698340-4ABE6ADB-596D-4B34-908E-795CFAE1A259Q34225473-4109FD8D-D2B2-4342-8B3B-9FB4ABC77342Q34722715-E4927F03-FC8B-40B9-934A-43A08EA539CAQ36568724-DF61D1E7-211B-4344-8EAA-6EF386AC599BQ43194576-43001B5E-FD8D-40F9-A05C-F52895AB1127Q44105146-CD35B9C3-6FA7-4E36-AAEA-F0742D0DBCCAQ44115953-4AB4CEEB-6BAB-4085-BFA7-EFA413D471FEQ44186930-67A89287-05EE-47AC-BBB3-2D489561247BQ44535163-FAE400BF-D742-49B0-AD3D-306026B3B1B1Q45038579-6DF8DBB1-F38E-435E-9613-01FA45BC251DQ45250885-BCAE8516-2BD6-4CAA-B284-E1EFE8BA1228Q46879636-BF891427-D99A-48CE-A3B8-EDBD53AA71EBQ53345728-2850731D-70B9-46F1-AD42-1E07A535D647
P2860
Selection of lower cutoff point of [13C]urea breath test is helpful to monitor H. pylori eradication after proton pump inhibitor-based triple therapy.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Selection of lower cutoff poin ...... nhibitor-based triple therapy.
@en
Selection of lower cutoff poin ...... nhibitor-based triple therapy.
@nl
type
label
Selection of lower cutoff poin ...... nhibitor-based triple therapy.
@en
Selection of lower cutoff poin ...... nhibitor-based triple therapy.
@nl
prefLabel
Selection of lower cutoff poin ...... nhibitor-based triple therapy.
@en
Selection of lower cutoff poin ...... nhibitor-based triple therapy.
@nl
P2093
P356
P1476
Selection of lower cutoff poin ...... nhibitor-based triple therapy.
@en
P2093
P2888
P304
P356
10.1023/A:1005599818959
P577
2000-07-01T00:00:00Z
P6179
1049562742